News

I've noticed a common thread running through many of the GLP-1 forums and social media groups I follow. Women are getting pregnant while taking medications like Ozempic, Wegovy, Zepbound, Mounjaro, Saxenda, Trulicity, and Victoza. In many cases, the posts start the same way: "We'd been trying for years." "I thought I couldn't get pregnant." "I was waiting to start fertility treatment." Then comes the surprise positive pregnancy test. The phenomenon has become common enough th

Two million people get married each year, according to the CDC. GLP-1 usage (Ozempic, Wegovy, Zepbound, etc.) stands at around 40 million users. When those two statistics meet, it can cause additional anxiety around wedding dress selection, deadlines, timelines, and more. It's not new that a bride or groom wants to look their best during their wedding week. What is new is the change in the obesity and weight loss landscape brought on by the GLP-1 revolution. Rapid weight loss

The race to develop effective oral GLP-1 medications for obesity is heating up, and AstraZeneca is officially making its move. If you're like me, that means you're also seeing hope that the out-of-pocket costs of these medications, which include Ozempic, Zepbound, and Wegovy, will go down in the future as more players enter the field. At the 2026 American Diabetes Association Scientific Sessions, AstraZeneca announced positive Phase 2b results for elecoglipron. The medication

For years, my future seemed pretty straightforward. At some point, I was going to need a knee replacement. I have bone-on-bone osteoarthritis in both knees. Every orthopedic appointment seemed to end with the same conversation. The surgery wasn't necessarily needed today, but it was coming eventually. The only question was when. To further complicate and concern my health, my mother passed away after her second knee replacement surgery. Blood clots entered her lungs the day a

If you’re a Medicare beneficiary interested in weight-loss medications like Wegovy, Zepbound, or Foundayo, the Medicare GLP-1 Bridge could be a game-changer. I know I've gotten many questions from Medicare recipients about how to get into the GLP-1 revolution. This new, short-term demonstration program launched by the Centers for Medicare & Medicaid Services (CMS) gives eligible Medicare Part D beneficiaries access to certain GLP-1 medications for just $50 per month. What Is

The landscape of diabetes and obesity management made a significant transformation in 2026, driven by the development of oral glucagon-like peptide-1 (GLP-1) receptor agonists. That means the idea of popular weight loss drugs, like tirzepatide and semaglutide, are now easier to swallow literally, figuratively, and financially. Traditionally administered via injection, GLP-1 therapies are now being formulated into pill forms, promising greater accessibility and adherence for p

Retatrutide is being called the “triple threat” of weight loss drugs—and it’s not even on the market yet. Developed by Eli Lilly, the same pharmaceutical giant behind tirzepatide (better known as Mounjaro and Zepbound), this new contender is generating buzz for its potential to help people lose more weight, faster.

Several people have messaged the GLP-1 Newsroom recently about planning vacations and asking, "Can I travel with Ozempic/Zepbound?" or another GLP-1. The answer is a resounding, yes. Whether you’re jetting off for a beach vacation or hitting the road to visit family, traveling with GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound requires a little planning—but it’s totally doable.

You may have seen the headlines about Eli Lilly’s orforglipron outperforming Novo Nordisk’s oral semaglutide. On the surface, it sounds...

The FDA just gave the green light for Wegovy (semaglutide) to treat metabolic-associated steatohepatitis (MASH) in adults with moderate...

As a Zepbound user, I'm what they call a "super responder." In six months, I lost about 100 pounds. Now, there are tests under a science...

GLP-1s like Wegovy and Zepbound exploded onto the health scene in the past few years. The injectable meds make a big health difference in...

Can drugs like semaglutide and tirzepatide cause pancreatitis? Yes, they can. That part isn’t in dispute. It’s listed in the official prescribing info from both Novo Nordisk and Eli Lilly. But what dramatic headlines don’t tell you is that the actual risk is low, and there’s a ton of context missing.

On June 17, 2025, the announcement of a partnership between 9amHealth and Mark Cuban's Cost Plus crossed the news wires. The news release reads, in part, "This collaboration brings together Cost Plus Drugs' groundbreaking transparent pricing model and 9amHealth's high-touch, at a time where patient demand and rising medical costs have come to a head."

It looked like clickbait. An article about man noticing at least an inch or more length in their penis after losing weight on GLP-1s like Ozempic. In fact, it's now nicknamed Ozempic Penis or (my favorite) OzemDick. Could a weight loss medication also contribute to male enhancement?

We keep hearing that GLP-1s are changing the way Americans eat, but most coverage still treats the average user like a faceless calorie counter. That’s not the story. New research from IFF breaks down the GLP-1 diet trends.

GLP-1 medications like Ozempic and Zepbound are best known for helping with blood sugar and weight, but researchers are starting to...

MAY 30, 2025 — New GLP-1 diet and lifestyle guidelines are poised to help first-time users navigate the real work that comes after the...

If you’re using Ozempic or another GLP-1 medication and your mouth feels like a desert, it’s not just in your head. "Ozempic teeth" has...

GLP-1 medications like semaglutide and tirzepatide have reshaped the way we talk about weight loss. People who’ve struggled for years are finally seeing results, but the risk of losing muscle mass is real. Could bimagrumab be the medication that solves this GLP-1 challenge?